Denali Therapeutics Secures $130,000,000 Series B Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=da9b96f4-9c07-4950-b959-b26fbc64d885
Date
8/26/2016
Company Name
Denali Therapeutics
Mailing Address
151 Oyster Point Blvd. South San Francisco, CA 94080 USA
Company Description
Denali is founded on the collaboration of leading scientists, industry experts and investors who share the vision that scientific discovery energetically applied to translational medicine is the key to delivering effective therapies to patients.
Website
http://www.denalitherapeutics.com
Transaction Type
Venture Equity
Transaction Amount
$130,000,000
Transaction Round
Series B
Proceeds Purposes
The company will use the funding to fund its drug candidate pipeline.
M&A Terms
Venture Investor
Baillie Gifford
Venture Investor
Undisclosed